PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT04661150

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive…

This is a phase II, multicenter, randomized, open-label study designed to evaluate the efficacy and safety of perioperative trastuzumab+XELOX with / without ate…

China42 participantsStarted 2021-03-12

Treatment: Atezolizumab, Trastuzumab

UnknownPhase 2

NCT05466019

A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-…

In this study, patients with PD-L1 positive locally advanced patients with resectable gastric cancer or gastroesophageal junction adenocarcinoma were invited to…

China30 participantsStarted 2021-05-01

Treatment: Drug: Toripalimab, FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU)